Date | Analyst | Company | Last | Target | Call | Valuation |
07/26/24 | DBS Vickers | Ifast Corp | 7.11 | 9.57 | Buy | DCF |
07/29/24 | UOB Kay Hian | Ifast Corp | 7.5 | 8.03 | Hold | |
07/30/24 | CIMB | Ifast Corp | 7.43 | 9.5 | Add | |
10/28/24 | DBS Vickers | Ifast Corp | 7.75 | 9.57 | Buy | DCF |
10/28/24 | Lim & Tan | Ifast Corp | 7.75 | 9.26 | Hold | |
10/29/24 | UOB Kay Hian | Ifast Corp | 7.65 | 8.17 | Hold | PER25x FY25 |
10/30/24 | CIMB | Ifast Corp | 7.47 | 9.5 | Add | |
02/13/25 | DBS Vickers | Ifast Corp | 7.65 | 10.23 | Buy | DCF |
02/13/25 | Lim & Tan | Ifast Corp | 7.65 | 0 | Hold | |
02/14/25 | UOB Kay Hian | Ifast Corp | 7.87 | 8.3 | Hold | PER25x FY25 |
03/12/25 | DBS Vickers | Ifast Corp | 7.75 | 10.88 | Buy | DCF |
04/10/25 | DBS Vickers | Ifast Corp | 6.2 | 10.88 | Buy | DCF |
04/28/25 | Lim & Tan | Ifast Corp | 7.19 | 9.42 | Hold | |
04/29/25 | UOB Kay Hian | Ifast Corp | 6.35 | 7.28 | Buy | PER25x FY25 |
04/29/25 | DBS Vickers | Ifast Corp | 6.35 | 9.22 | Buy | DCF |
05/05/25 | Lim & Tan | Ifast Corp | 6.3 | 7 | Hold |
Thursday, June 5, 2025
Ifast Corp - Stock calls
Hyphens Pharma - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
08/21/24 | Phillip | Hyphens Pharma | 0.29 | 0.35 | Buy | DCF |
08/26/24 | SAC Capital | Hyphens Pharma | 0.285 | 0.38 | Buy | |
09/11/24 | CIMB | Hyphens Pharma | 0.29 | 0.4 | Add | DCF |
11/18/24 | CIMB | Hyphens Pharma | 0.28 | 0.35 | Add | DCF |
03/10/25 | Phillip | Hyphens Pharma | 0.28 | 0.35 | Buy | DCF |
03/12/25 | SAC Capital | Hyphens Pharma | 0.28 | 0.46 | Buy |
Stock calls for 5 June 2025
Date | Analyst | Company | Last | Target | Call | Valuation |
06/05/25 | UOB Kay Hian | City Developments | 4.99 | 4.6 | Hold | PB0.72x |
06/05/25 | Lim & Tan | City Developments | 4.99 | 5.91 | Accumulate | |
06/05/25 | Lim & Tan | Grand Venture | 0.935 | 0 | Hold | |
06/05/25 | SIAS | Singapore Paincare | 0.157 | 0.365 | Hold | Offer @ $0.16 |
06/05/25 | DBS Vickers | UOL | 6.02 | 8.4 | Buy | RNAV (40% disc) |
Red alert: OECD has downgraded the US and global growth. - Part 2
It looks like the OECD is right to downgrade the US growth because the service PMI has just moved into the contractionary zone. From the chart above, the previous contraction was about 1 year ago. Since the US is a service oriented economy with consumption making up close to 70% of GDP, this decline in service PMI will impact the US GDP heavily.
Subscribe to:
Comments (Atom)
